Tacit Therapeutics

South San Francisco, United States

Tacit Therapeutics created RNA-targeting treatments for devastating diseases.

$19.0M raised

Mar 2026

Series A

Biotechnology Genetics Health Care Medical

Top Investors

National Science Foundation Civilization Ventures KdT Ventures Michigan Capital Network Eisai Innovation

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Tacit Therapeutics

How much funding has Tacit Therapeutics raised?

Tacit Therapeutics has raised $19.0M in total funding. The most recent round was Series A. The last funding was announced in March 2026.

Who are Tacit Therapeutics's investors?

Tacit Therapeutics's investors include National Science Foundation, Civilization Ventures, KdT Ventures, Michigan Capital Network, Eisai Innovation.

Where is Tacit Therapeutics headquartered?

Tacit Therapeutics is headquartered in South San Francisco, United States.

What does Tacit Therapeutics do?

Tacit Therapeutics created RNA-targeting treatments for devastating diseases.

What stage is Tacit Therapeutics at?

Tacit Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 9, 2026.

MLA

"Tacit Therapeutics — Funding & Investors." VCBacked, March 9, 2026, https://www.vcbacked.co/company/tacit-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2026). Tacit Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/tacit-therapeutics

Wikipedia (cite web)

{{cite web |title=Tacit Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/tacit-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 9, 2026.

Similar Companies in Biotechnology

View all

Rapport Therapeutics

Boston$250.0M

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K